North America Automated Cell Cultures Market Analysis

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

North America Automated Cell Cultures Market Analysis

  • Healthcare
  • Published Report
  • Sep 2022
  • North America
  • 350 Pages
  • No of Tables: 85
  • No of Figures: 35

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 REGULATORY FRAMEWORK FOR NORTH AMERICA AUTOMATED CELL CULTURES MARKET

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING DEMAND FOR CELL CULTURE TECHNOLOGY IN VACCINE PRODUCTION

6.1.2 TECHNOLOGICAL ADVANCEMENTS IN CELL CULTURE TECHNOLOGY SYSTEMS

6.1.3 WIDE ACCEPTANCE OF CELL CULTURE TECHNIQUES IN VARIOUS APPLICATIONS

6.1.4 GROWING BIOTECHNOLOGY SECTOR, ALONG WITH RISING HEALTHCARE EXPENDITURE

6.1.5 ADVANTAGES OF AUTOMATED CELL CULTURE SYSTEMS OVER MANUAL METHODS

6.2 RESTRAINTS

6.2.1 HIGH COST OF AUTOMATED CELL CULTURE SYSTEMS

6.2.2 LIMITATIONS ASSOCIATED WITH AUTOMATED CELL CULTURES

6.2.3 MAINTENANCE AND UPDATING OF EQUIPMENT

6.2.4 LACK OF SKILLED AND CERTIFIED PROFESSIONALS

6.3 OPPORTUNITIES

6.3.1 NEW PRODUCT LAUNCHES AND TECHNOLOGY DEVELOPMENTS

6.3.2 INCREASING COLLABORATION AMONG MARKET PLAYERS

6.3.3 INCREASING OUTSOURCING FACILITIES

6.3.4 INCREASE IN DEMAND FOR 3D CELL CULTURE

6.4 CHALLENGES

6.4.1 DEVELOPMENT AND MAINTENANCE OF EXPERTISE

6.4.2 LACK OF INFRASTRUCTURE FOR CELL-BASED RESEARCH IN EMERGING ECONOMIES

7 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY PRODUCT

7.1 OVERVIEW

7.2 CONSUMABLES

7.2.1 MEDIA

7.2.1.1 SERUM FREE MEDIA

7.2.1.2 CLASSICAL MEDIA & SALTS

7.2.1.3 STEM CELL CULTURE MEDIA

7.2.1.4 SPECIALTY MEDIA

7.2.2 BUFFERS AND SUPPLEMENTS

7.2.2.1 PLASMA

7.2.2.2 SERA

7.2.2.3 FETAL BOVINE SERA

7.2.2.4 ADULT BOVINE SERA

7.2.2.5 OTHERS ANIMAL SERA

7.2.3 REAGENTS

7.2.3.1 SUPPLEMENTS & GROWTH FACTORS

7.2.3.2 BUFFERS & CHEMICALS

7.2.3.3 CELL DISASSOCIATION REAGENTS

7.2.3.4 BALANCED SALT SOLUTIONS

7.2.3.5 ATTACHMENT & MATRIX FACTORS

7.2.3.6 ANTIBIOTICS/ANTIMYCOTICS

7.2.3.7 CONTAMINATION DETECTION KITS

7.2.3.8 CRYOPROTECTIVE REAGENTS

7.2.3.9 OTHERS CELL CULTURE REAGENTS

7.2.4 ACCESSORIES

7.3 INSTRUMENTS

7.3.1 SUPPORTING EQUIPMENTS

7.3.1.1 CELL COUNTERS

7.3.1.2 IMAGE BASED CELL COUNTERS

7.3.1.3 FLOW CYTOMETERS

7.3.1.4 COULTER COUNTERS

7.3.1.5 CELL EXPANSION

7.3.1.6 LIQUID HANDLERS

7.3.1.7 OTHERS

7.3.2 BIOREACTORS

7.3.2.1 SINGLE USE BIOREACTORS

7.3.2.2 CONVENTIONAL BIOREACTORS

7.3.2.3 OTHERS

7.3.3 STORAGE EQUIPMENTS

7.3.3.1 REFRIGERATORS & FREEZERS

7.3.3.2 CRYOSTORAGE SYSTEMS

7.3.3.3 OTHERS

8 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY TYPE

8.1 OVERVIEW

8.2 INFINITE CELL LINE CULTURES

8.3 FINITE CELL LINE CULTURES

9 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 DRUG DEVELOPMENT

9.3 STEM CELL RESEARCH

9.3.1 EMBRYONIC STEM CELLS

9.3.2 TISSUE-SPECIFIC STEM CELLS

9.3.3 MESENCHYMAL STEM CELLS

9.3.4 INDUCED PLURIPOTENT STEM CELLS

9.4 REGENERATIVE MEDICINE

9.4.1 STEM CELL THERAPY

9.4.2 PLATELET-RICH PLASMA THERAPY (OR PRP INJECTIONS)

9.4.3 TISSUE ENGINEERING

9.4.4 AMNIOTIC-MEMBRANE DERIVED STEM CELLS

9.5 CANCER RESEARCH

9.6 VACCINES

9.7 OTHERS

10 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY END USER

10.1 OVERVIEW

10.2 BIOTECH COMPANIES

10.3 RESEARCH ORGANIZATIONS

10.4 ACADEMIC RESEARCH INSTITUTES

10.5 OTHERS

11 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY REGION

11.1 NORTH AMERICA

11.1.1 U.S.

11.1.2 CANADA

11.1.3 MEXICO

12 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

13 COMPANY PROFILE

13.1 LONZA

13.1.1 COMPANY SNAPSHOT

13.1.2 REVENUE ANALYSIS

13.1.3 COMPANY SHARE ANALYSIS

13.1.4 PRODUCT PORTFOLIO

13.1.5 RECENT DEVELOPMENTS

13.1.6 SWOT ANALYSIS

13.2 MERCK KGAA

13.2.1 COMPANY SNAPSHOT

13.2.2 RECENT FINANCIALS

13.2.3 COMPANY SHARE ANALYSIS

13.2.4 PRODUCT PORTFOLIO

13.2.5 RECENT DEVELOPMENTS

13.2.6 SWOT ANALYSIS

13.3 THERMO FISHER SCIENTIFIC INC.

13.3.1 COMPANY SNAPSHOT

13.3.2 RECENT FINANCIALS

13.3.3 COMPANY SHARE ANALYSIS

13.3.4 PRODUCT PORTFOLIO

13.3.5 RECENT DEVELOPMENTS

13.3.6 SWOT ANALYSIS

13.4 BD

13.4.1 COMPANY SNAPSHOT

13.4.2 RECENT FINANCIALS

13.4.3 COMPANY SHARE ANALYSIS

13.4.4 PRODUCT PORTFOLIO

13.4.5 RECENT DEVELOPMENTS

13.4.6 SWOT ANALYSIS

13.5 EPPENDORF AG

13.5.1 COMPANY SNAPSHOT

13.5.2 REVENUE ANALYSIS

13.5.3 COMPANY SHARE ANALYSIS

13.5.4 PRODUCT PORTFOLIO

13.5.5 RECENT DEVELOPMENTS

13.5.6 SWOT ANALYSIS

13.6 ADVANCED INSTRUMENTS

13.6.1 COMPANY SNAPSHOT

13.6.2 PRODUCT PORTFOLIO

13.6.3 RECENT DEVELOPMENTS

13.7 BENCHMARK SCIENTIFIC INC.

13.7.1 COMPANY SNAPSHOT

13.7.2 PRODUCT PORTFOLIO

13.7.3 RECENT DEVELOPMENTS

13.8 BIOSPHERIX LTD.

13.8.1 COMPANY SNAPSHOT

13.8.2 PRODUCT PORTFOLIO

13.8.3 RECENT DEVELOPMENTS

13.9 BIOTRON HEALTHCARE

13.9.1 COMPANY SNAPSHOT

13.9.2 PRODUCT PORTFOLIO

13.9.3 RECENT DEVELOPMENTS

13.1 BULLDOG-BIO, INC.

13.10.1 COMPANY SNAPSHOT

13.10.2 PRODUCT PORTFOLIO

13.11 CELL CULTURE COMPANY, LLC

13.11.1 COMPANY SNAPSHOT

13.11.2 PRODUCT PORTFOLIO

13.11.3 RECENT DEVELOPMENT

13.12 CELLGENIX GMBH

13.12.1 COMPANY SNAPSHOT

13.12.2 PRODUCT PORTFOLIO

13.12.3 RECENT DEVELOPMENTS

13.13 CHEMOMETEC

13.13.1 COMPANY SNAPSHOT

13.13.2 REVENUE ANALYSIS

13.13.3 PRODUCT PORTFOLIO

13.13.4 RECENT DEVELOPMENT

13.14 CORNING INCORPORATED

13.14.1 COMPANY SNAPSHOT

13.14.2 RECENT FINANCIALS

13.14.3 PRODUCT PORTFOLIO

13.14.4 RECENT DEVELOPMENTS

13.15 CYTIVA (SUBSIDIARY OF DANAHER CORPORATION)

13.15.1 COMPANY SNAPSHOT

13.15.2 REVENUE ANALYSIS

13.15.3 PRODUCT PORTFOLIO

13.15.4 RECENT DEVELOPMENTS

13.16 FUJIFILM HOLDINGS AMERICA CORPORATION

13.16.1 COMPANY SNAPSHOT

13.16.2 REVENUE ANALYSIS

13.16.3 PRODUCT PORTFOLIO

13.16.4 RECENT DEVELOPMENTS

13.17 HAMILTON COMPANY

13.17.1 COMPANY SNAPSHOT

13.17.2 PRODUCT PORTFOLIO

13.17.3 RECENT DEVELOPMENTS

13.18 HITACHI, LTD.

13.18.1 COMPANY SNAPSHOT

13.18.2 REVENUE ANALYSIS

13.18.3 PRODUCT PORTFOLIO

13.18.4 RECENT DEVELOPMENTS

13.19 KAWASAKI HEAVY INDUSTRIES, LTD.

13.19.1 COMPANY SNAPSHOT

13.19.2 REVENUE ANALYSIS

13.19.3 PRODUCT PORTFOLIO

13.19.4 RECENT DEVELOPMENTS

13.2 HIMEDIA LABORATORIES

13.20.1 COMPANY SNAPSHOT

13.20.2 PRODUCT PORTFOLIO

13.20.3 RECENT DEVELOPMENTS

13.21 NANOENTEK AMERICA INC. (A SUBSIDIARY OF NANOENTEK)

13.21.1 COMPANY SNAPSHOT

13.21.2 PRODUCT PORTFOLIO

13.21.3 RECENT DEVELOPMENTS

13.22 NEXCELOM BIOSCIENCE LLC.

13.22.1 COMPANY SNAPSHOT

13.22.2 PRODUCT PORTFOLIO

13.22.3 RECENT DEVELOPMENTS

13.23 PROMOCELL GMBH

13.23.1 COMPANY SNAPSHOT

13.23.2 PRODUCT PORTFOLIO

13.23.3 RECENT DEVELOPMENTS

13.24 RWD LIFE SCIENCE CO LTD.

13.24.1 COMPANY SNAPSHOT

13.24.2 PRODUCT PORTFOLIO

13.24.3 RECENT DEVELOPMENTS

13.25 SARTORIUS AG

13.25.1 COMPANY SNAPSHOT

13.25.2 REVENUE ANALYSIS

13.25.3 PRODUCT PORTFOLIO

13.25.4 RECENT DEVELOPMENTS

13.26 SCIENTICA INSTRUMENTATION, INC.

13.26.1 COMPANY SNAPSHOT

13.26.2 PRODUCT PORTFOLIO

13.26.3 RECENT DEVELOPMENTS

13.27 SHIBUYA CORPORATION

13.27.1 COMPANY SNAPSHOT

13.27.2 RECENT FINANCIALS

13.27.3 PRODUCT PORTFOLIO

13.27.4 RECENT DEVELOPMENTS

13.28 SPHERE FLUIDICS LIMITED

13.28.1 COMPANY SNAPSHOT

13.28.2 PRODUCT PORTFOLIO

13.28.3 RECENT DEVELOPMENTS

13.29 TECAN TRADING AG

13.29.1 COMPANY SNAPSHOT

13.29.2 RECENT FINANCIALS

13.29.3 PRODUCT PORTFOLIO

13.29.4 RECENT DEVELOPMENT

13.3 THRIVE BIOSCIENCE, INC.

13.30.1 COMPANY SNAPSHOT

13.30.2 PRODUCT PORTFOLIO

13.30.3 RECENT DEVELOPMENTS

14 QUESTIONNAIRE

15 RELATED REPORTS

List of Table

TABLE 1 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 2 NORTH AMERICA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 3 NORTH AMERICA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 4 NORTH AMERICA MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 5 NORTH AMERICA BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 6 NORTH AMERICA REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCTS, 2020-2029 (EURO MILLION)

TABLE 7 NORTH AMERICA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 8 NORTH AMERICA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 9 NORTH AMERICA SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 10 NORTH AMERICA BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 11 NORTH AMERICA STORAGE EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 12 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 13 NORTH AMERICA INFINITE CELL LINE CULTURES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 14 NORTH AMERICA FINITE CELL LINE CULTURES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 15 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 16 NORTH AMERICA DRUG DEVELOPMENT IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 17 NORTH AMERICA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 18 NORTH AMERICA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 19 NORTH AMERICA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 20 NORTH AMERICA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 21 NORTH AMERICA CANCER RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 22 NORTH AMERICA VACCINES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 23 NORTH AMERICA OTHERS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 24 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 25 NORTH AMERICA BIOTECH COMPANIES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 26 NORTH AMERICA RESEARCH ORGANIZATIONS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 27 NORTH AMERICA ACADEMIC RESEARCH INSTITUTES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 28 NORTH AMERICA OTHERS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 29 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY COUNTRY, 2020-2029 (EURO MILLION)

TABLE 30 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 31 NORTH AMERICA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 32 NORTH AMERICA MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 33 NORTH AMERICA BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 34 NORTH AMERICA REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 35 NORTH AMERICA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 36 NORTH AMERICA SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 37 NORTH AMERICA BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 38 NORTH AMERICA STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 39 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 40 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 41 NORTH AMERICA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 42 NORTH AMERICA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 43 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 44 U.S. AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 45 U.S. CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 46 U.S. MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 47 U.S. BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 48 U.S. REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 49 U.S. INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 50 U.S. SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 51 U.S. BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 52 U.S. STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 53 U.S. AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 54 U.S. AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 55 U.S. STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 56 U.S. REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 57 U.S. AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 58 CANADA AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 59 CANADA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 60 CANADA MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 61 CANADA BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 62 CANADA REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 63 CANADA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 64 CANADA SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 65 CANADA BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 66 CANADA STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 67 CANADA AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 68 CANADA AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 69 CANADA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 70 CANADA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 71 CANADA AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 72 MEXICO AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 73 MEXICO CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 74 MEXICO MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 75 MEXICO BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 76 MEXICO REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 77 MEXICO INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 78 MEXICO SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 79 MEXICO BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 80 MEXICO STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 81 MEXICO AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 82 MEXICO AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 83 MEXICO STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 84 MEXICO REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 85 MEXICO AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

List of Figure

FIGURE 1 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: DBMR MARKET POSITION GRID

FIGURE 8 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: SEGMENTATION

FIGURE 11 WIDE ACCEPTANCE OF CELL CULTURE TECHNIQUES IN VARIOUS APPLICATIONS AND THE GROWING BIOTECHNOLOGY SECTOR ARE EXPECTED TO DRIVE THE NORTH AMERICA AUTOMATED CELL CULTURES MARKET IN THE FORECAST PERIOD

FIGURE 12 CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA AUTOMATED CELL CULTURES MARKET IN 2022 & 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA AUTOMATED CELL CULTURES MARKET

FIGURE 14 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY PRODUCT, 2021

FIGURE 15 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY PRODUCT, 2022-2029 (EURO MILLION)

FIGURE 16 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY PRODUCT, CAGR (2022-2029)

FIGURE 17 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 18 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY TYPE, 2021

FIGURE 19 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY TYPE, 2022-2029 (EURO MILLION)

FIGURE 20 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 21 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY TYPE, LIFELINE CURVE

FIGURE 22 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY APPLICATION, 2021

FIGURE 23 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY APPLICATION, 2022-2029 (EURO MILLION)

FIGURE 24 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 25 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 26 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY END USER, 2021

FIGURE 27 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY END USER, 2022-2029 (EURO MILLION)

FIGURE 28 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY END USER, CAGR (2022-2029)

FIGURE 29 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY END USER, LIFELINE CURVE

FIGURE 30 NORTH AMERICA AUTOMATED CELL CULTURES MARKET : SNAPSHOT (2021)

FIGURE 31 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2021)

FIGURE 32 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2022 & 2029)

FIGURE 33 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2021 & 2029)

FIGURE 34 NORTH AMERICA AUTOMATED CELL CULTURES MARKET : BY PRODUCT (2022-2029)

FIGURE 35 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: COMPANY SHARE 2021 (%)

Frequently Asked Questions

The market segments covered By Product, Type, Application, and End User.
The countries data covered in the report are the U.S., Canada, and Mexico
In 2022, The North America automated cell cultures market is expected to grow due to increasing applications in stem cell research, vaccine production, regenerative medicines production, and drug discovery.
The player's dominating the market are Lonza, Merck KGaA, Thermo Fisher Scientific Inc., BD, Eppendorf AG, and Others